FVF2
MCRB icon

Flagship Ventures Fund 2007’s Seres Therapeutics MCRB Stock Holding History

Flagship Ventures Fund 2007’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$15.9M Buy
+29,965
New +$15.6M 16.72% 2

Other funds holding MCRB

FVFI
Flagship Ventures Fund IV Cambridge, Massachusetts $382M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Flagship Ventures Fund 2007's MCRB Position: Q1 2016 in Review

Flagship Ventures Fund 2007 opened a new position in Seres Therapeutics (MCRB) in Q1 2016: 29,965 shares worth $15.9M. The stake represents 16.72% of the portfolio and ranks #2 among its holdings.

76 funds tracked by Wall St. Rank hold MCRB as of Q1 2016.

  • Flagship Ventures Fund 2007 held 29,965 shares of Seres Therapeutics worth $15.9M as of Q1 2016.
  • Seres Therapeutics was a new Flagship Ventures Fund 2007 position in Q1 2016.
  • Seres Therapeutics made up 16.72% of Flagship Ventures Fund 2007's portfolio in Q1 2016, its #2 holding.
  • 76 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2016.

Based on Flagship Ventures Fund 2007's 13F filing for Q1 2016, filed 13 May 2016.